| abstract |
A pharmaceutical composition for oral administration comprising bendamustine or a pharmaceutically acceptable ester, salt or solution thereof as an active ingredient, as well as a pharmaceutically acceptable excipient which is a pharmaceutically acceptable nonionic surfactant selected from the group consisting of macrogol glycerol hydroxystearate, polyoxyl. 35-castor oil and ethylene oxide / propylene oxide block copolymer (Pluronic® L44 NF or Poloxamer® 124). The application contains 12 more claims. |